Literature DB >> 20683900

Dichotomy between factors inducing the immunosuppressive enzyme IL-4-induced gene 1 (IL4I1) in B lymphocytes and mononuclear phagocytes.

Jeanine Marquet1, Fanette Lasoudris, Céline Cousin, Marie-Line Puiffe, Nadine Martin-Garcia, Véronique Baud, Fanny Chereau, Jean-Pierre Farcet, Valérie Molinier-Frenkel, Flavia Castellano.   

Abstract

MPhi and DC are key elements in the control of tissue homeostasis and response to insult. In this work, we demonstrate that MPhi and DC are the major producers of the phenylalanine catabolizing enzyme IL-4-induced gene 1 (IL4I1) under inflammatory conditions. IL4I1 was first described in B cells, which indeed can produce IL4I1 in vitro, although at much lower levels. In vivo, IL4I1 is highly expressed by MPhi and DC of Th1 granulomas (sarcoidosis, tuberculosis) but poorly detected in Th2 granulomas (schistosomiasis). In vitro, expression of the enzyme is induced in mononuclear phagocytes by various pro-inflammatory stimuli through the activation of the transcription factors NF-kappaB and/or STAT1. B cells also express IL4I1 in response to NF-kappaB-activating stimuli such as CD40L; however, in contrast to myeloid cells, B cells are insensitive to IFN-gamma but respond to stimulation of the IL-4/STAT6 axis. As we show that the expression of IL4I1 by a monocytic cell line inhibits T-cell proliferation and production of IFN-gamma and inflammatory cytokines, we propose that IL4I1 participates in the downregulation of Th1 inflammation in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683900      PMCID: PMC3001484          DOI: 10.1002/eji.201040428

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes.

Authors:  Andreas J Schroder; Paul Pavlidis; Akinori Arimura; Danielle Capece; Paul B Rothman
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

2.  [Systemic granulomatosis. Anatomy/pathology of granuloma].

Authors:  J F Emile
Journal:  Rev Med Interne       Date:  2005-04-15       Impact factor: 0.728

Review 3.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

4.  Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling.

Authors:  D A Frank; S Mahajan; J Ritz
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

5.  IFN regulatory factor-2 cooperates with STAT1 to regulate transporter associated with antigen processing-1 promoter activity.

Authors:  Marie-Christine Rouyez; Marta Lestingi; Martine Charon; Serge Fichelson; Agnès Buzyn; Isabelle Dusanter-Fourt
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

6.  A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation.

Authors:  Shomyseh Sanjabi; Kevin J Williams; Simona Saccani; Liang Zhou; Alexander Hoffmann; Gourisankar Ghosh; Steve Gerondakis; Gioacchino Natoli; Stephen T Smale
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 11.361

7.  Fig1, an interleukin 4-induced mouse B cell gene isolated by cDNA representational difference analysis.

Authors:  C C Chu; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages.

Authors:  A Carbonnelle-Puscian; C Copie-Bergman; M Baia; N Martin-Garcia; Y Allory; C Haioun; A Crémades; I Abd-Alsamad; J-P Farcet; P Gaulard; F Castellano; V Molinier-Frenkel
Journal:  Leukemia       Date:  2009-01-29       Impact factor: 11.528

9.  Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells.

Authors:  Fanny Baran-Marszak; Jean Feuillard; Imen Najjar; Christophe Le Clorennec; Jean-Marie Béchet; Isabelle Dusanter-Fourt; Georg W Bornkamm; Martine Raphaël; Remi Fagard
Journal:  Blood       Date:  2004-06-24       Impact factor: 22.113

10.  Thrombopoietin activates a STAT5-like factor in hematopoietic cells.

Authors:  C Pallard; F Gouilleux; L Bénit; L Cocault; M Souyri; D Levy; B Groner; S Gisselbrecht; I Dusanter-Fourt
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  19 in total

1.  Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes.

Authors:  Deanna M Santer; Alice E Wiedeman; Thomas H Teal; Pradipta Ghosh; Keith B Elkon
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

2.  IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.

Authors:  Lloyd Bod; Renée Lengagne; Ludovic Wrobel; Jan Philipp Ramspott; Masashi Kato; Marie-Françoise Avril; Flavia Castellano; Valérie Molinier-Frenkel; Armelle Prévost-Blondel
Journal:  Oncoimmunology       Date:  2017-01-13       Impact factor: 8.110

3.  N-linked glycosylation enrichment for in-depth cell surface proteomics of diffuse large B-cell lymphoma subtypes.

Authors:  Sally J Deeb; Juergen Cox; Marc Schmidt-Supprian; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2013-11-04       Impact factor: 5.911

4.  Quantitative Analysis of Proteome Modulations in Alveolar Epithelial Type II Cells in Response to Pulmonary Aspergillus fumigatus Infection.

Authors:  Pegah Seddigh; Thilo Bracht; Válerie Molinier-Frenkel; Flavia Castellano; Olaf Kniemeyer; Marc Schuster; Juliane Weski; Anja Hasenberg; Andreas Kraus; Gernot Poschet; Thomas Hager; Dirk Theegarten; Christiane A Opitz; Axel A Brakhage; Barbara Sitek; Mike Hasenberg; Matthias Gunzer
Journal:  Mol Cell Proteomics       Date:  2017-09-26       Impact factor: 5.911

5.  IL4I1: an inhibitor of the CD8⁺ antitumor T-cell response in vivo.

Authors:  Fanette Lasoudris; Céline Cousin; Armelle Prevost-Blondel; Nadine Martin-Garcia; Issam Abd-Alsamad; Nicolas Ortonne; Jean-Pierre Farcet; Flavia Castellano; Valérie Molinier-Frenkel
Journal:  Eur J Immunol       Date:  2011-05-13       Impact factor: 5.532

6.  Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Authors:  Noton K Dutta; Peter B Illei; Sanjay K Jain; Petros C Karakousis
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

7.  What role for AHR activation in IL4I1-mediated immunosuppression ?

Authors:  Flavia Castellano; Armelle Prevost-Blondel; José L Cohen; Valérie Molinier-Frenkel
Journal:  Oncoimmunology       Date:  2021-05-12       Impact factor: 8.110

Review 8.  Antimicrobial properties of L-amino acid oxidase: biochemical features and biomedical applications.

Authors:  Kosuke Kasai; Manabu Nakano; Masami Ohishi; Toshiya Nakamura; Tomisato Miura
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-09       Impact factor: 4.813

9.  Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study.

Authors:  Mari Levula; Niku Oksala; Nina Airla; Rainer Zeitlin; Juha-Pekka Salenius; Otso Järvinen; Maarit Venermo; Teemu Partio; Jukka Saarinen; Taija Somppi; VeliPekka Suominen; Jyrki Virkkunen; Juha Hautalahti; Reijo Laaksonen; Mika Kähönen; Ari Mennander; Leena Kytömäki; Juhani T Soini; Jyrki Parkkinen; Markku Pelto-Huikko; Terho Lehtimäki
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

10.  Antibacterial properties of the mammalian L-amino acid oxidase IL4I1.

Authors:  Marie-Line Puiffe; Isabelle Lachaise; Valérie Molinier-Frenkel; Flavia Castellano
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.